Patent Assignment
Reel/Frame 071062/0545
Change of Name
Recorded: 2025-05-08
Pages: 5
Assignor
MARINUS PHARMACEUTICALS, INC.
Executed: 2025-02-25
Assignee
IMMEDICA PHARMA US INC.
150 N. MICHIGAN AVENUE, SUITE 1950, CHICAGO, ILLINOIS, 60601
Covered Properties
(3)
Ganaxolone for Use in Treating Tuberous Sclerosis Complex and Seizure Disorders
Ganaxolone for Use in Treating Tuberous Sclerosis Complex and Seizure Disorders
Application:
18/829,810 →
Publication:
US 2025/0032512
Ganaxolone for Use in Treating Tuberous Sclerosis Complex and Seizure Disorders
Related Assignments
(3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Sep 13, 2024
From: HULIHAN, JOSEPH; AIMETTI, ALEX; BRAUNSTEIN, SCOTT
To: MARINUS PHARMACEUTICALS, INC.
Reel/Frame 068576/0121 →
Assignment of Assignor's Interest
Oct 8, 2024
From: HULIHAN, JOSEPH; AIMETTI, ALEX; BRAUNSTEIN, SCOTT
To: MARINUS PHARMACEUTICALS, INC.
Reel/Frame 068824/0688 →
Assignment of Assignor's Interest
Oct 8, 2024
From: HULIHAN, JOSEPH; AIMETTI, ALEX; BRAUNSTEIN, SCOTT
To: MARINUS PHARMACEUTICALS, INC.
Reel/Frame 068824/0694 →